Free Trial

Allogene Therapeutics (ALLO) Earnings Date, Estimates & Call Transcripts

Allogene Therapeutics logo
$1.94 +0.05 (+2.65%)
Closing price 04:00 PM Eastern
Extended Trading
$1.94 +0.01 (+0.26%)
As of 05:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Allogene Therapeutics Latest Earnings Summary

Upcoming Q1
Earnings Date
May. 12After Market ClosesEstimated
Actual EPS
(Mar. 13)
-$0.28 Beat By $0.06
Consensus EPS
(Mar. 13)
-$0.34

Allogene Therapeutics announced Q4 2024 earnings on March 13, 2025, reporting an EPS of -$0.28, which topped analysts' consensus estimates of -$0.34 by $0.06. With a trailing EPS of -$1.56, Allogene Therapeutics' earnings are expected to decrease next year, from ($1.28) to ($1.35) per share.

ALLO Upcoming Earnings

Allogene Therapeutics' next earnings date is estimated for Monday, May 12, 2025, based off prior year's reporting schedules.

Get Allogene Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Allogene Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ALLO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALLO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

Allogene Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20253-$0.38-$0.33-$0.35
Q2 20253-$0.38-$0.34-$0.36
Q3 20253-$0.40-$0.35-$0.37
Q4 20253-$0.43-$0.36-$0.38
FY 202512-$1.59-$1.38-$1.46
Q1 20261-$0.40-$0.40-$0.40
Q2 20261-$0.43-$0.43-$0.43
Q3 20261-$0.45-$0.45-$0.45
Q4 20261-$0.47-$0.47-$0.47
FY 20264($1.75)($1.75)($1.75)
Remove Ads

Allogene Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/12/2025
(Estimated)
-------
3/13/2025Q4 2024-$0.34-$0.28+$0.06-$0.28$0.01M-
8/7/2024Q2 2024-$0.35-$0.32+$0.03-$0.29--
5/13/2024Q1 2024-$0.41-$0.38+$0.03-$0.38$0.01M$0.02M
3/14/2024Q4 2023-$0.47-$0.43+$0.04-$0.35$0.05M$0.02M
11/2/2023Q3 2023-$0.53-$0.37+$0.16-$0.37$0.05M$0.04M
8/2/2023Q2 2023-$0.59-$0.53+$0.06-$0.53$0.01M$0.04M
5/3/2023Q1 2023-$0.63-$0.68 -$0.05-$0.68$0.08M$0.05M

Allogene Therapeutics Earnings - Frequently Asked Questions

Allogene Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based off last year's report dates. Learn more on ALLO's earnings history.

In the previous quarter, Allogene Therapeutics (NASDAQ:ALLO) reported ($0.28) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.34) by $0.06. Learn more on analysts' earnings estimate vs. ALLO's actual earnings.

The conference call for Allogene Therapeutics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Allogene Therapeutics's latest earnings report can be read online.
Read Transcript

Allogene Therapeutics (NASDAQ:ALLO) has a recorded annual revenue of $43,000.00.

Allogene Therapeutics (NASDAQ:ALLO) has a recorded net income of -$327.27 million. ALLO has generated -$1.56 earnings per share over the last four quarters.

Allogene Therapeutics's earnings are expected to decrease from ($1.28) per share to ($1.35) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:ALLO) was last updated on 3/14/2025 by MarketBeat.com Staff
From Our Partners